Savara Inc. announced that Badrul Chowdhury, M.D., Ph.D., has resigned from his role as Chief Medical Officer, effective September 9, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.04 USD | -1.70% | +0.50% | -14.04% |
05-21 | Oppenheimer Adjusts Savara Price Target to $11 From $9.50, Maintains Outperform Rating | MT |
05-09 | Savara Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.04% | 568M | |
+16.93% | 124B | |
+17.01% | 109B | |
-7.23% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-6.79% | 16.61B | |
-37.63% | 16.43B | |
+2.17% | 13.4B | |
+24.42% | 11.47B |
- Stock Market
- Equities
- SVRA Stock
- News Savara Inc.
- Savara Announces Resignation of Badrul Chowdhury as Chief Medical Officer, Effective on September 9, 2022